About Charles Baum
Charles Baum is an executive chairman at Terremoto Biosciences.
Form D filings also name Charles Baum as a director at Odyssey Therapeutics.
Charles Baum reports to the SEC as a director or officer of 7 public companies, including Acrivon Therapeutics (ACRV), PMV Pharmaceuticals (PMVP) and Poseida Therapeutics (PSTX).
Charles Baum first appears on SEC filings in 2013.
Experience
This experience comes from Charles Baum's profile and from SEC filings. For roles taken from filings, the years are when the filings name Charles Baum in the role, so the role may have started earlier or lasted longer.
Terremoto Biosciences, Inc. Current
Executive Chairman
Executive Chair of the Board of Directors (2023 – Present)
2023 – Present · South San Francisco, CA
Develops targeted medicines for patients with cancer and genetic diseases.
AI
Acrivon Therapeutics, Inc. Current
Director
2023 – Present · Public company (ACRV)
PI
PMV Pharmaceuticals, Inc. Current
Director
2021 – Present · Public company (PMVP)
AO
ALX Oncology Current
Member Scientific Advisory Board
2020 – Present
PI
Poseida Therapeutics, Inc.
Director
2022 – 2025 · Public company (PSTX)
MI
Mirati Therapeutics, Inc.
Founder, President, and CEO, director
Chief Executive Officer, President and Founder (2012 – 2024)
2012 – 2024 · Public company (MRTX)
II
Immunomedics Inc.
Member Board Of Directors
2019 – 2020 · Public company (IMMU)
TI
Tango Therapeutics, Inc.
Director
2020 · Public company (TNGX)
AI
Array Biopharma Inc.
Member Board of Directors
2014 – 2019 · Public company (ARRY)
PF
Pfizer
Senior Vice President
2003 – 2012
SI
Schering-Plough Research Institute
Senior Director
2000 – 2003
TL
The SEARLE Company Ltd.
Senior Director
1995 – 2000
EU
Emory University
Assistant Professor
1992 – 1994
Key Colleagues at Startups
The people Charles Baum works with at each company, as listed on that company's latest Form D.
Terremoto Biosciences, Inc. · Form D, Apr 22, 2026
MG
Michael Goller
Director
GL
Grace Lu
Executive officer
James Christensen
President and Chief Executive Officer, director
Reid Huber
Partner, Third Rock Ventures and director
Peter Thompson
Co-founder and Director, Terremoto
DC
Daniel O'Connell
Director
Odyssey Therapeutics, Inc. · Form D/A, Aug 14, 2024
TW
Timothy Walbert
Director
GG
Gary Glick
President & CEO, director
JC
Jill Carroll
Director
JL
Jeffrey Leiden
Director
IS
Ian Smith
Director
VO
Valerie Odegard
Director
LK
Lorence Kim
Director
CG
Carl Gordon
Director